P. Yeske

发表

[3 + 2] Cyclization-elimination route to cyclopentenyl sulfones using (phenylsulfonyl)-1,2-propadiene

A. Padwa, P. Yeske, 1991 .

Benzaldehyde oxime as a 1,3-dipole chameleon

A. Padwa, W. Dent, P. Yeske, 1987 .

Cycloaddition of (phenylsulfonyl)-1,2-propadienes with diazomethane. Novel rearrangement reactions of the resulting cycloadducts

A. Padwa, D. Kline, S. Murphree, 1993 .

Synthesis of cyclopentenyl sulfones via the [3 + 2] cyclization-elimination reaction of (phenylsulfonyl)allene

A. Padwa, P. Yeske, 1988 .

(3 + 2)Cyclization-Elimination Route to Cyclopentenyl Sulfones Using ( Phenylsulfonyl)-1,2-propadienes.

A. Padwa, P. Yeske, 1992 .

Use of 2,3-bis(phenylsulfonyl)-1-propene as a multicoupling reagent

A. Padwa, D. Kline, S. Murphree, 1992 .

Amine chemistries for isocyanate-based coatings

D. Wicks, P. Yeske, 1997 .

Tunable regioselectivity associated with the reaction of 2,3-dihalo-1-(phenylsulfonyl)-1-propenes with ambident nucleophilic reagents

D. Austin, A. Padwa, S. Murphree, 1992 .

International Workshop: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16–18 November 2016, Rome, Italy

M. Zeviani, H. Prokisch, M. Mancuso, 2017, Neuromuscular Disorders.

Mitochondrial Disease Sequence Data Resource (MSeqDR): a global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities.

Marcella Attimonelli, Xiaowu Gai, Lishuang Shen, 2015, Molecular genetics and metabolism.

Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Marni J. Falk, Kathryn M. Camp, L. Wolfe, 2016, Molecular genetics and metabolism.

Recent applications of radical reactions in natural product synthesis

D. Curran, J. Sisko, H. Liu, 1993 .

Synthesis of vinylic and cyclic sulfones via a radical addition-elimination sequence

A. Padwa, S. Murphree, P. Yeske, 1990 .

Generation and cycloaddition reactions of phenylsulfonyl-substituted 1,3-butadienes

A. Padwa, B. Harrison, S. Murphree, 1989 .

Harmonizing care for rare diseases: How we developed the mitochondrial care network in the United States.

S. Parikh, A. Goldstein, A. Karaa, 2019, Molecular genetics and metabolism.

Risk mitigation behaviors to prevent infection in the mitochondrial disease community during the COVID-19 pandemic

Eliza M. Gordon-Lipkin, C. Marcum, M. Hirano, 2021, Molecular Genetics and Metabolism Reports.

Community Consensus Guidelines to Support FAIR Data Standards in Clinical Research Studies in Primary Mitochondrial Disease

J. Christodoulou, S. Rahman, F. Scaglia, 2021, Advanced genetics.

The evolution of the mitochondrial disease diagnostic odyssey

J. Krischer, D. Dimmock, K. Engelstad, 2023, Orphanet Journal of Rare Diseases.

258th ENMC international workshop Leigh syndrome spectrum: genetic causes, natural history and preparing for clinical trials 25-27 March 2022, Hoofddorp, Amsterdam, The Netherlands

Marni J. Falk, H. Prokisch, A. Rötig, 2023, Neuromuscular Disorders.

Navigating Life With Primary Mitochondrial Myopathies: The Importance of the Patient Voice and Implications for Clinical Practice

Margaret C. Moore, S. Parikh, P. Yeske, 2023, Journal of primary care & community health.

Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Marni J. Falk, Kathryn M. Camp, J. Vockley, 2016, Molecular genetics and metabolism.

International Workshop: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16–18 November 2016, Rome, Italy

M. Zeviani, H. Prokisch, M. Mancuso, 2017, Neuromuscular Disorders.